Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer-Reference-Cited by-同舟云学术

Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer

Published:2016-06 Issue:1 Volume:376 Page:155-164
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chen Mingwei,Zhuang Chengle,Liu Yuchen,Li Jianfa,Dai Fen,Xia Ming,Zhan Yonghao,Lin Junhao,Chen Zhicong,He Anbang,Xu Wen,Zhao Guoping,Guo Yinglu,Cai Zhiming,Huang Weiren

Funder

National Key Basic Research Program of China

Chinese High-Tech

National Natural Science Foundation of China

International S&T Cooperation program of China (ISTCP)

National Science Foundation Projects of Guangdong Province

Shenzhen Municipal Government of China

Special Support Funds of Shenzhen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: a meta-analysis;Tian;J. Huazhong Univ. Sci. Technol. Med. Sci,2015

2. Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus;Zhang;Oncotarget,2015

3. Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy;Suer;World J. Urol,2015

4. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus calmette-guerin;Cambier;Eur. Urol,2016

5. Principles of long noncoding RNA evolution derived from direct comparison of transcriptomes in 17 species;Hezroni;Cell Rep,2015

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p/FOXC1 axis;Cell Death & Disease;2024-09-03

2. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06

3. Long non-coding RNA HIF1A-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma;Pathology - Research and Practice;2024-01

4. Rho GTPase‐activating protein 1 promotes hepatocellular carcinoma progression via modulation by CircPIP5K1A/MiR‐101‐3p;Hepatology Research;2023-10-16

5. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies;Biomedicine & Pharmacotherapy;2023-09